NATR — NATURES SUNSHINE PRODUCTS INC
—
Nasdaq ·
Health Care ·
Pharmaceuticals ·
CIK 275053 ·
Last close
$21.89
Market Cap
$384.93M
52W High
$28.14
52W Low
$21.14
ADV30
91,996
Next earnings
2026-07-30
Quarterly Fundamentals
Revenues vs Net Income (last 4 Q)
Assets vs Liabilities (last 4 Q)
| Period | Revenues | GrossProfit | OpIncome | NetIncome | Assets | Cash | Liabilities |
|---|---|---|---|---|---|---|---|
| Mar 2026 | 122,892,000 | 89,977,000 | 9,545,000 | 5,118,000 | 261,458,000 | 87,578,000 | 94,542,000 |
| Dec 2025 | 123,807,000 | 89,779,000 | 5,322,000 | 4,107,000 | 261,146,000 | 93,891,000 | 99,593,000 |
| Sep 2025 | 128,339,000 | 94,049,000 | 8,975,000 | 5,334,000 | 264,805,000 | 95,554,000 | 98,101,000 |
| Jun 2025 | 114,750,000 | 82,299,000 | 4,274,000 | 5,333,000 | 254,875,000 | 81,345,000 | 91,193,000 |
Cashflow TTM (yfinance, fills SEC gap)
Operating CF
$35,321,000
Investing CF
$-6,480,000
Financing CF
$-23,773,000
CapEx
$-6,480,000
Dividends Paid
—
Buybacks
$-16,309,000
EPS Diluted TTM
$1.06
As of
2026-05-10
Balance + Analyst (yfinance extras)
Retained Earnings
$76,928,000
Inventory
$68,312,000
Receivables
$8,602,000
ST Investments
—
EBIT TTM
$29,910,000
Pretax Income TTM
$29,812,000
Interest Exp TTM
$98,000
Analysts
2
Yahoo Snapshot (yfinance, live)
Total Revenue
$489,788,000
EBITDA
$41,685,000
Free Cash Flow
$23,175,500
Enterprise Value
$319,784,832
Total Cash
$87,578,000
Total Debt
$22,430,000
Shares Out
17,584,871
Trailing EPS
$1.10
Book Value
$9.23
ROE
12.4%
ROA
6.8%
Div Yield
—
Annual Trend (SEC EDGAR, last 4y)
Revenues vs Net Income (last 4y)
| FY end | Revenues | OpIncome | NetIncome | Assets | Liabilities | Equity | OCF |
|---|---|---|---|---|---|---|---|
| Dec 2025 | 480,144,000 | 24,743,000 | 19,521,000 | 261,146,000 | 99,593,000 | — | 35,321,000 |
| Dec 2024 | 454,364,000 | 20,095,000 | 7,696,000 | 240,855,000 | 79,864,000 | — | 25,298,000 |
| Dec 2023 | 445,320,000 | 18,749,000 | 15,076,000 | 249,773,000 | 90,233,000 | — | 41,226,000 |
| Dec 2022 | 421,910,000 | 16,258,000 | -390,000 | 229,778,000 | 82,731,000 | — | 710,000 |
TTM Snapshot
Revenues TTM
$440,105,000
NetIncome TTM
$13,010,000
OpCashFlow TTM
$0
Assets (Latest)
$240,855,000
Forward EPS
$1.28
Max Pain — expiry 2026-11-20 (volume-derived — Yahoo OI feed degraded)
max pain strike: $22.50 · spot: $21.89 · call volume: 35 · put volume: 6
Expected Move to 2026-11-20:
±$5.02
(22.93%) —
implied range
$16.87 –
$26.91
· ATM straddle on $22.50 strike
Peers — same industry
| Ticker | Name | Market Cap | Last | Daily % |
|---|---|---|---|---|
| VSTM | Verastem, Inc. | $383.13M | $4.36 | — |
| LYEL | Lyell Immunopharma, Inc. | $381.98M | $16.37 | — |
| GLSI | Greenwich LifeSciences, Inc. | $379.48M | $27.39 | — |
| BNTC | Benitec Biopharma Inc. | $393.36M | $11.45 | — |
| ENTA | ENANTA PHARMACEUTICALS INC | $393.43M | $13.53 | — |
News headlines (Yahoo Finance, 1h cache)
How The Nature’s Sunshine (NATR) Narrative Is Shifting With Q4 Beats And Digital Growth
2026-05-25 12:09 · Yahoo
Discovering US Undiscovered Gems in May 2026
2026-05-18 17:33 · Yahoo
NATR Q1 Deep Dive: Digital Channel Expansion and Margin Gains Shape Outlook
2026-05-11 22:12 · Yahoo
Nature's Sunshine Products, Inc. Just Beat EPS By 41%: Here's What Analysts Think Will Happen Next
2026-05-11 10:48 · Yahoo
Nature's Sunshine Products Q1 Earnings Call Highlights
2026-05-08 09:09 · Yahoo
Nature's Sunshine Products, Inc. Q1 2026 Earnings Call Summary
2026-05-08 00:45 · Yahoo
NATR Q1 2026 Earnings Transcript
2026-05-07 23:08 · Yahoo
Nature's Sunshine’s (NASDAQ:NATR) Q1 CY2026: Beats On Revenue
2026-05-07 20:14 · Yahoo
Nature's Sunshine Reports Strong First Quarter 2026 Results
2026-05-07 20:05 · Yahoo
Why One Fund Boosted Its PennyMac Stake Despite Mortgage Market Volatility
2026-05-07 18:26 · Yahoo
Recent Insider Activity
No insider activity indexed for this ticker.